
LGVN
USDLongeveron Inc. Class A Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$0.820
고가
$0.820
저가
$0.800
거래량
0.38M
기업 기본 정보
시가총액
16.8M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.95M
거래소
NCM
통화
USD
52주 범위
관련 뉴스
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions,
Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect
Laromestrocel is a proprietary, scalable, allogeneic cellular therapy being evaluated to improve the clinical outcomes of children with HLHSFull enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II)
관련 주식
RBCP
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
LLY
Eli Lilly and Company
AIRJ
Montana Technologies Corporation
NYMTM
New York Mortgage Trust Inc. 7.875% Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock
CVIIW
Churchill Capital Corp VII Warrants
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기